Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Asthma

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    September 2022
  1. TRAN C, Singh GV, Haider E, Boylan C, et al
    Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
    Respir Med. 2022;202:106982.
    PubMed     Abstract available


  2. ROCHE N, Aggarwal B, Boucot I, Mittal L, et al
    The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
    Respir Med. 2022;202:106949.
    PubMed     Abstract available


    August 2022
  3. BOURDIN A, Virchow JC, Papi A, Lugogo NL, et al
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
    Respir Med. 2022;202:106938.
    PubMed     Abstract available


  4. TAJIRI S, Kondo T, Tanigaki T, Hibino M, et al
    Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
    Respir Med. 2022;201:106950.
    PubMed     Abstract available


  5. CHAPMAN KR, Canonica GW, Lavoie KL, Nenasheva N, et al
    Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
    Respir Med. 2022;201:106948.
    PubMed     Abstract available


  6. CANONICA GW, Spanevello A, de Llano LP, Domingo Ribas C, et al
    Is asthma control more than just an absence of symptoms? An expert consensus statement.
    Respir Med. 2022;202:106942.
    PubMed     Abstract available


  7. TRELA KC, Zajac P, Zhu M, Press VG, et al
    Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse.
    Respir Med. 2022;200:106930.
    PubMed     Abstract available


    July 2022
  8. ORLOVIC M, Magni T, Lukyanov V, Guerra I, et al
    Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
    Respir Med. 2022;201:106934.
    PubMed     Abstract available


  9. LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
    Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
    Respir Med. 2022;201:106935.
    PubMed     Abstract available


  10. HENRY SL, Moore LE, Brotto AR, Rowland S, et al
    Systemic vascular health is compromised in both confirmed and unconfirmed asthma.
    Respir Med. 2022;200:106932.
    PubMed     Abstract available


  11. ALHABEEB FF, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
    Respir Med. 2022;200:106917.
    PubMed     Abstract available


    June 2022
  12. PATELLA V, Pelaia C, Zunno R, Pelaia G, et al
    Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
    Respir Med. 2022;200:106916.
    PubMed     Abstract available


  13. LIU L, Zhang X, Zhang L, Liu Y, et al
    Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
    Respir Med. 2022;200:106924.
    PubMed     Abstract available


  14. HUGHES R, Rapsomaniki E, Janson C, Keen C, et al
    Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
    Respir Med. 2022;200:106921.
    PubMed     Abstract available


  15. CAZZOLA M, Braido F, Calzetta L, Matera MG, et al
    The 5T approach in asthma: Triple Therapy Targeting Treatable Traits.
    Respir Med. 2022;200:106915.
    PubMed     Abstract available


  16. LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
    Associations of asthma self-management and mental health in adolescents: A scoping review.
    Respir Med. 2022;200:106897.
    PubMed     Abstract available


    May 2022
  17. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    PubMed     Abstract available


  18. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    PubMed     Abstract available


  19. JIAO T, Schnitzer ME, Forget A, Blais L, et al
    Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
    Respir Med. 2022;198:106866.
    PubMed     Abstract available


  20. GOLAM SM, Janson C, Beasley R, FitzGerald JM, et al
    The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
    Respir Med. 2022;200:106863.
    PubMed     Abstract available


    March 2022
  21. KORN S, Milger K, Skowasch D, Timmermann H, et al
    Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793].
    Respir Med. 2022;196:106827.
    PubMed    


    February 2022
  22. KORN S, Milger K, Skowasch D, Timmermann H, et al
    The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
    Respir Med. 2022;195:106793.
    PubMed     Abstract available


  23. BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
    Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
    Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
    PubMed     Abstract available


  24. AL-AHMAD M, Webb D
    A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
    Respir Med. 2022;194:106771.
    PubMed     Abstract available


    January 2022
  25. JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
    Mental health in patients with asthma: A population-based case-control study.
    Respir Med. 2022;193:106758.
    PubMed     Abstract available


  26. VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
    Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
    Respir Med. 2022;193:106757.
    PubMed     Abstract available


  27. BOURDIN A, Molinari N
    Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
    Respir Med. 2022;191:105999.
    PubMed    


  28. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
    Respir Med. 2022;191:106088.
    PubMed    


  29. MARTIN N, Papi A, Bratton DJ, Chan R, et al
    Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
    Respir Med. 2022;191:106065.
    PubMed    


  30. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
    Respir Med. 2022;191:105991.
    PubMed     Abstract available


  31. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2022;191:106106.
    PubMed    


    December 2021
  32. MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
    Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
    Respir Med. 2021;191:106724.
    PubMed     Abstract available


  33. PENG J, Wu F, Tian H, Yang H, et al
    Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
    Respir Med. 2021;190:106681.
    PubMed     Abstract available


    November 2021
  34. FAN Q, Ong ASE, Koh MS, Doshi K, et al
    The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
    Respir Med. 2021;190:106673.
    PubMed     Abstract available


  35. ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
    Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
    Respir Med. 2021;188:106621.
    PubMed     Abstract available


    October 2021
  36. CZIRA A, Turner M, Martin A, Hinds D, et al
    A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
    Respir Med. 2021;191:106670.
    PubMed     Abstract available


  37. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
    Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
    Respir Med. 2021;189:106639.
    PubMed     Abstract available


  38. RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
    Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
    Respir Med. 2021;187:106595.
    PubMed     Abstract available


  39. AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
    Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
    Respir Med. 2021;187:106572.
    PubMed     Abstract available


  40. RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
    Risk factors for irreversible airway obstruction after infant bronchiolitis.
    Respir Med. 2021;187:106545.
    PubMed     Abstract available


    June 2021
  41. AL-QEREM WA, Jarab AS
    Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
    Respir Med. 2021;182:106397.
    PubMed     Abstract available


    May 2021
  42. CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
    Sedentary time in people with obstructive airway diseases.
    Respir Med. 2021;181:106367.
    PubMed     Abstract available


    April 2021
  43. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    PubMed     Abstract available


    January 2021
  44. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    PubMed     Abstract available


  45. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: